An Update on the Potential Application of Herbal Medicine in Promoting Angiogenesis
Jingjing Li, Renkai Li, Xiaoping Wu, Chengwen Zheng, Polly Ho-Ting Shiu, Panthakarn Rangsinth, Simon Ming‐Yuen Lee, Gph Leung
Abstract
Angiogenesis, the formation of new capillaries from pre-existing vascular networks, plays an important role in many physiological and pathological processes. The use of pro-angiogenic agents has been proposed as an attractive approach for promoting wound healing and treating vascular insufficiency-related problems, such as ischemic heart disease and stroke, which are the leading causes of death worldwide. Traditional herbal medicine has a long history; however, there is still a need for more in-depth studies and evidence-based confirmation from controlled and validated trials. Many in vitro and in vivo studies have reported that herbal medicines and their bioactive ingredients exert pro-angiogenic activity. The most frequently studied pro-angiogenic phytochemicals include ginsenosides from Panax notoginseng , astragalosides and calycosin from Radix Astragali, salvianolic acid B from Salvia miltiorrhiza , paeoniflorin from Radix Paeoniae, ilexsaponin A1 from Ilex pubescens , ferulic acid from Angelica sinensis , and puerarin from Radix puerariae. This review summarizes the progress in research on these phytochemicals, particularly those related to pro-angiogenic mechanisms and applications in ischemic diseases, tissue repair, and wound healing. In addition, an outline of their limitations and challenges during drug development is presented.